Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open‐flow microperfusion

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dom.12551PMID 26260082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Open flow microperfusion: pharmacokinetics of human insulin and insulin detemir in the interstitial fluid of subcutaneous adipose tissue

  2015cited by this paper
• Pharmacodynamics of the long‐acting insulin analogues detemir and glargine following single‐doses and under steady‐state conditions in patients with type 1 diabetes

  2014cited by this paper
• Open Flow Microperfusion: An Alternative Method to Microdialysis?

  2013cited by this paper
• A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes

  2013cited by this paper
• Insulin entry into muscle involves a saturable process in the vascular endothelium

  2012cited by this paper
• A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

  2012cited by this paper
• Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10

  2012cited by this paper
• Comparison of Open-Flow Microperfusion and Microdialysis Methodologies When Sampling Topically Applied Fentanyl and Benzoic Acid in Human Dermis Ex Vivo

  2012cited by this paper
• A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

  2011cited by this paper
• Time-action profiles of insulin detemir in normal and diabetic dogs.

  2011cited by this paper
• Insulin detemir attenuates food intake, body weight gain and fat mass gain in diet-induced obese Sprague–Dawley rats

  2011cited by this paper
• Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects

  2010cited by this paper
• Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor

  2010cited by this paper
• Insulin detemir is not transported across the blood-brain barrier.

  2010cited by this paper
• Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes

  2008cited by this paper
• Physiological Hyperinsulinemia Has No Detectable Effect on Access of Macromolecules to Insulin-Sensitive Tissues in Healthy Humans

  2007cited by this paper
• DIABETICMedicine Blackwell Publishing Ltd Original Article: Treatment DOI: 10.1111/j.1464-5491.2008.02407.x

  2007cited by this paper
• Proportional Dose-Response Relationship and Lower Within-Patient Variability of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes Mellitus

  2007cited by this paper
• Refining basal insulin therapy: what have we learned in the age of analogues?

  2007cited by this paper
• Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

  2007cited by this paper
• Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

  2005cited by this paper
• A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

  2005cited by this paper
• Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

  2005cited by this paper
• Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access.

  2005cited by this paper
• ACTIVE ROLE FOR THE VASCULATURE IN THE DELIVERY OF INSULIN TO SKELETAL MUSCLE

  2005cited by this paper
• Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

  2004cited by this paper
• The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

  2004cited by this paper
• Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

  2004cited by this paper
• Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir

  2004cited by this paper
• Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle.

  2003cited by this paper
• Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects.

  2000cited by this paper
• Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans.

  2000cited by this paper
• Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion.

  2000cited by this paper
• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

  2000cited by this paper
• Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin

  1999cited by this paper
• Lactate metabolism of subcutaneous adipose tissue studied by open flow microperfusion.

  1998cited by this paper
• Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs

  1996cited by this paper
• Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men.

  1994cited by this paper
• Fully enzymatic inulin determination in small volume samples without deproteinization.

  1992cited by this paper
• Measurement of renal function in chronic renal disease.

  1990cited by this paper
• A microdialysis method allowing characterization of intercellular water space in humans.

  1987cited by this paper
• Human Insulin

  1986cited by this paper
• Vascular Health and Risk Management Dovepress an Update on the Treatment of Type 1 and Type 2 Diabetes Mellitus: Focus on Insulin Detemir, a Long-acting Human Insulin Analog

  year unknowncited by this paper

• Chain splitting of insulin: an underlying mechanism of insulin resistance?

  2024cites this paper
• Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model

  2023cites this paper
• Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugs.

  2022cites this paper
• (Pro)renin receptor and insulin signaling regulate cell proliferation in MCF-7 breast cancer cells.

  2022cites this paper
• A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment

  2021cites this paper
• A Novel Minimally Invasive OFM Technique Combined Orthotopic Transplantation of hUC-MSCs with in vivo Monitoring of Liver Metabolic Microenvironment in Liver Fibrosis Treatment

  2021cites this paper
• Is insulin intoxication still the perfect crime? Analysis and interpretation of postmortem insulin: review and perspectives in forensic toxicology

  2020cites this paper
• Comparative effects of different whole grains and brans on blood lipid: a network meta-analysis

  2018cites this paper
• Quantification of Basal Insulin Peglispro and Human Insulin in Adipose Tissue Interstitial Fluid by Open-Flow Microperfusion

  2017cites this paper
• Toward Hydrogel Microneedle Patches for The Passive Extraction of Subcutaneous Interstitial Fluid

  2017cites this paper
• Cerebral open flow microperfusion (cOFM) an innovative interface to brain tissue.

  2016cites this paper
• Microdialysis of Large Molecules.

  2016cites this paper